Canada markets open in 5 hours 51 minutes

Cue Biopharma, Inc. (CUE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9050+0.0050 (+0.26%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 92.67M
Enterprise Value 58.85M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)15.88
Price/Book (mrq)2.50
Enterprise Value/Revenue 10.72
Enterprise Value/EBITDA -1.28

Trading Information

Stock Price History

Beta (5Y Monthly) 2.01
52-Week Change 3-58.68%
S&P500 52-Week Change 323.57%
52 Week High 35.1200
52 Week Low 31.3030
50-Day Moving Average 31.8492
200-Day Moving Average 32.4752

Share Statistics

Avg Vol (3 month) 3282.6k
Avg Vol (10 day) 3347.31k
Shares Outstanding 548.64M
Implied Shares Outstanding 648.64M
Float 845.38M
% Held by Insiders 12.97%
% Held by Institutions 132.89%
Shares Short (Apr 15, 2024) 44.78M
Short Ratio (Apr 15, 2024) 417.99
Short % of Float (Apr 15, 2024) 410.12%
Short % of Shares Outstanding (Apr 15, 2024) 49.82%
Shares Short (prior month Mar 15, 2024) 44.12M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-750.96%

Management Effectiveness

Return on Assets (ttm)-42.53%
Return on Equity (ttm)-98.73%

Income Statement

Revenue (ttm)5.49M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)1,106.00%
Gross Profit (ttm)N/A
EBITDA -51.44M
Net Income Avi to Common (ttm)-50.73M
Diluted EPS (ttm)-1.1100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)48.51M
Total Cash Per Share (mrq)1
Total Debt (mrq)14.7M
Total Debt/Equity (mrq)39.63%
Current Ratio (mrq)3.01
Book Value Per Share (mrq)0.79

Cash Flow Statement

Operating Cash Flow (ttm)-39.96M
Levered Free Cash Flow (ttm)-20.2M